| Citation: |
TANG Libin, GU Xiaoli, HE Weiyaozhen, QI Fei, XIA Jiawei, LI Haiwen. Influencing factors of liver cirrhosis patients complicated with hepatopulmonary syndrome and diagnostic value of contrast echocardiography of right heart[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 11-15, 20. DOI: 10.7619/jcmp.20220470
|
To analyze the influencing factors of liver cirrhosis patients complicated with hepatopulmonary syndrome (HPS) and diagnostic value of contrast echocardiography of right heart.
A total of 286 patients diagnosed as liver cirrhosis and meeting the screening criteria from July 2019 to February 2021 were selected as research objects. Indicators of blood routine, liver function, renal function, coagulation function, endothelin-1 (ET-1) and tumor necrosis factor-α (TNF-α) levels were detected in all patients within 3 days before right cardiography examination were detected, and the diagnostic sensitivity and adverse reactions of right phonography for HPS were observed. Incidence and risk factors of HPS were analyzed, and the correlations of semi-quantitative microbubble volume with the severity of HPS, liver function, ET-1 and TNF-α were analyzed.
Of 286 patients with liver cirrhosis in this study, 36 cases were positive in contrast echocardiography of right heart, and 32 cases were clinically diagnosed as HPS. Univariate analysis and multifactor Logistic regression analysis showed that grade C of Child-Pugh classification, D-dimer, ET-1 and TNF-α were the risk factors for HPS (P < 0.05). In 32 patients with HPS, 17 cases had small amount of microbubbles, 10 cases had medium amount of microbubbles, and 5 cases had large amount of microbubbles. The number of microbubbles in contrast echocardiography of right heart was positively correlated with HPS classification and serum ET-1 (P < 0.01).
Grade C of Child-Pugh classification and high levels of D-dimer, ET-1 and TNF-α are the risk factors for HPS in liver cirrhosis patients. Contrast echocardiography of right heart has a high sensitivity in the diagnosis of HPS, and the semi-quantitative determination of contrast echocardiography of right heart can predict the severity of HPS.
| [1] |
TUMGOR G. Cirrhosis and hepatopulmonary syndrome[J]. World J Gastroenterol, 2014, 20(10): 2586-2594. doi: 10.3748/wjg.v20.i10.2586
|
| [2] |
蔡均均, 张倩, 韩涛. 肝肺综合征的诊治对策[J]. 中华肝脏病杂志, 2020, 28(5): 386-390. doi: 10.3760/cma.j.cn501113-20200424-00211
|
| [3] |
GRILO-BENSUSAN I, PASCASIO-ACEVEDO J M. Hepatopulmonary syndrome: what we know and what we would like to know[J]. World J Gastroenterol, 2016, 22(25): 5728-5741. doi: 10.3748/wjg.v22.i25.5728
|
| [4] |
VILLA E, FATTOVICH G, MAURO A, et al. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis[J]. Dig Liver Dis, 2011, 43(Suppl 1): S8-S14.
|
| [5] |
KROWKA M J, FALLON M B, KAWUT S M, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension[J]. Transplantation, 2016, 100(7): 1440-1452. doi: 10.1097/TP.0000000000001229
|
| [6] |
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华传染病杂志, 2019, 37(12): 711-736. doi: 10.3760/cma.j.issn.1000-6680.2019.12.003
|
| [7] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 939-946. doi: 10.3969/j.issn.1001-5256.2018.05.006
|
| [8] |
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华肝脏病杂志, 2019, 27(12): 938-961. doi: 10.3760/cma.j.issn.1007-3418.2019.12.007
|
| [9] |
RODRÍGUEZ-ROISIN R, KROWKA M J. Hepatopulmonary syndrome: a liver-induced lung vascular disorder[J]. N Engl J Med, 2008, 358(22): 2378-2387. doi: 10.1056/NEJMra0707185
|
| [10] |
IQBAL S, SMITH K A, KHUNGAR V. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation[J]. Clin Chest Med, 2017, 38(4): 785-795. doi: 10.1016/j.ccm.2017.08.002
|
| [11] |
SHARMA N S, WILLE K M, DIAZ GUZMAN E. Extracorporeal membrane oxygenation after liver transplantation in a patient with hepatopulmonary syndrome and an atrial septal defect[J]. Int J Artif Organs, 2015, 38(3): 170-172. doi: 10.5301/ijao.5000399
|
| [12] |
李梅. 肝肺综合征的超声影像学研究进展[J]. 实用心脑肺血管病杂志, 2011, 19(6): 1060-1061. doi: 10.3969/j.issn.1008-5971.2011.06.120
|
| [13] |
刘以俊, 李涛. 《2016年国际肝移植学会实践指南: 肝肺综合征与门脉性肺动脉高压的诊断与管理》摘译[J]. 临床肝胆病杂志, 2016, 32(10): 1838-1842. doi: 10.3969/j.issn.1001-5256.2016.10.002
|
| [14] |
谭年花, 陈斌. 慢加亚急性肝衰竭大鼠肠源性内毒素血症时Th17/Treg表达变化的实验研究[J]. 湖南中医杂志, 2019, 35(3): 134-138. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201903063.htm
|
| [15] |
RAEVENS S, FALLON M B. Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models[J]. Hepatology, 2018, 68(5): 2016-2028. doi: 10.1002/hep.30079
|
| [16] |
RAEVENS S, GEERTS A, VAN STEENKISTE C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment[J]. Liver Int, 2015, 35(6): 1646-1660. doi: 10.1111/liv.12791
|
| [17] |
石明霞, 张薇, 刘磊, 等. D-二聚体测定在慢性阻塞性肺疾病的疗效评价及预后意义的研究进展[J]. 现代生物医学进展, 2017, 17(29): 5797-5800. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201729047.htm
|
| [18] |
黎尚荣, 沈宁, 易慧敏, 等. 肝肺综合征病人体肺循环及血浆iNOS、ET-1水平变化[J]. 南方医科大学学报, 2009, 29(10): 2030-2032. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJD200910024.htm
|
| [19] |
王立国, 郭月宁, 刘喃喃, 等. 肿瘤坏死因子α在大鼠肝肺综合征发病机制研究[J]. 现代生物医学进展, 2021, 21(2): 219-222. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202102006.htm
|
| [20] |
程凯, 杨振林, 吕长俊. ET-1、NO、NOS、ETB受体在大鼠肝肺综合征作用中的初步研究[J]. 滨州医学院学报, 2011, 34(6): 401-406. https://www.cnki.com.cn/Article/CJFDTOTAL-BZYB201106002.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: